Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dl 3-117
2. Dl 3117
3. Dl-3-117
4. Iotrol
5. Isovist
6. Isovist 300
7. Osmovist
1. Iotrol
2. 79770-24-4
3. Isovist
4. Osmovist
5. Isovist 300
6. Dl-3117
7. Compound Zk 39482
8. Zk 39 482
9. 1,3-benzenedicarboxamide, 5,5'-((1,3-dioxo-1,3-propanediyl)bis(methylimino))bis(n,n'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodo-
10. Iotrovist
11. 16fl47b687
12. 2,4,6-triiodo-5-[methyl-[3-oxo-3-[2,4,6-triiodo-n-methyl-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]amino]-1-n,3-n-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide
13. 5,5'-(malonylbis(methylimino))bis(n,n'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodoisophthalamide)
14. Zk-39482
15. Zk-39-482
16. Iotrolanum [latin]
17. Osmovist 190
18. Osmovist 240
19. Iotrolanum
20. Iotrolum
21. Iotrolum [inn-latin]
22. Dl 3-117
23. Sh 437
24. Zk 39482
25. Unii-16fl47b687
26. Iotrolan(isovist)
27. Iotrolan [usan:inn:ban:jan]
28. Iotrolan [usan]
29. Iotrolan [inn]
30. Iotrolan [jan]
31. Iotrolan [mi]
32. Iotrolan [vandf]
33. Isovist 300 (tn)
34. Iotrolan [mart.]
35. Iotrolan [who-dd]
36. Schembl25535
37. Iotrolan (jan/usan/inn)
38. Iotrolan [orange Book]
39. Iotrolan For System Suitability
40. Iotrolan [ep Monograph]
41. Chembl1200555
42. Dtxsid0023165
43. Chebi:31715
44. Sh-l-437d
45. Db09487
46. Ft-0754152
47. D01714
48. 770i244
49. Q6064149
50. 5,5'-[(1,3-dioxopropane-1,3-diyl)bis(methylimino)]bis{n,n'-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodobenzene-1,3-dicarboxamide}
| Molecular Weight | 1626.2 g/mol |
|---|---|
| Molecular Formula | C37H48I6N6O18 |
| XLogP3 | -4.2 |
| Hydrogen Bond Donor Count | 16 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 24 |
| Exact Mass | 1625.7293 g/mol |
| Monoisotopic Mass | 1625.7293 g/mol |
| Topological Polar Surface Area | 400 Ų |
| Heavy Atom Count | 67 |
| Formal Charge | 0 |
| Complexity | 1450 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 8 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
V - Various
V08 - Contrast media
V08A - X-ray contrast media, iodinated
V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media
V08AB06 - Iotrolan
API SUPPLIERS
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5103
Submission : 1983-08-23
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5103
Submission : 1983-08-23
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
RLD : No
TE Code :
Brand Name : OSMOVIST 190
Dosage Form : INJECTABLE;INTRATHECAL
Dosage Strength : 40.6%
Approval Date : 1989-12-07
Application Number : 19580
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : OSMOVIST 240
Dosage Form : INJECTABLE;INTRATHECAL
Dosage Strength : 51.3%
Approval Date : 1989-12-07
Application Number : 19580
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Market Place
